An official website of the United States government
September 29, 2026 Edition
News
Antiviral drug did not improve Long COVID symptoms
A clinical trial for Long COVID found that treating patients with a common antiviral drug for up to 25 days did not improve symptoms.
News
tRNA treatment may help restore cystic fibrosis proteins
Lipid nanoparticles delivering engineered transfer RNA restored functional proteins in cell and animal models of cystic fibrosis.
News
Bacterial infection may alter developing gut
C. difficile bacteria caused lasting changes to cells in the intestines of newborn mice.
Displaying 491 - 497 of 912
Some brain functions may improve with age
Computer tests of attention and the ability to focus revealed that older adults actually improved in two of three key brain functions, at least until their mid-to-late 70s.
Early treatment with convalescent plasma for COVID-19 doesn't show benefit
Convalescent plasma did not prevent COVID-19 from worsening when given to high-risk patients within the first week of their symptoms.
How fructose may contribute to obesity and cancer
Researchers gained insights that may explain the links between high fructose consumption, obesity, and certain cancers.
Monoclonal antibody prevents malaria in early trial
A monoclonal antibody prevented malaria in people for up to 36 weeks in a Phase 1 clinical trial.
Vaccines prevented up to 140,000 COVID-19 deaths in U.S.
A study estimated that COVID-19 vaccinations prevented nearly 140,000 deaths in the U.S. by May 2021.
Highly processed foods form bulk of U.S. youths' diets
Highly processed foods accounted for two-thirds of the calories consumed by youth in the U.S. in 2018, researchers found.
Intranasal COVID-19 vaccine effective in animal studies
A nasal spray of a COVID-19 vaccine protected hamsters and monkeys against serious disease and reduced the amount of virus in the nose.